Financial Advantage, Inc. Stryker Corp Transaction History

Financial Advantage, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$194.09 - $276.37 $58,227 - $82,911	-300 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$197.98 - $220.53 $51,474 - $57,337	-260 Reduced 46.43%	300 $62,000
Q3 2019 Oct 23, 2019	BUY	$205.4 - $221.82 $53,404 - $57,673	260 Added 86.67%	560 $121,000
Q1 2019 Apr 17, 2019	BUY	$152.46 - $198.0 $45,738 - $59,400	300 New	300 $59,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Financial Advantage, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advantage, Inc. with notifications on news.